Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.

Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.

Item
http://www.wikidata.org/entity/Q33371653
Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review.Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantationInfliximab for the treatment of plaque psoriasis.Use of biologic therapeutics in difficult-to-treat psoriasis.Perioperative management of tumor necrosis factor antagonists in patients with psoriasis and other inflammatory disorders.A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease.Focus on skin cancer association and progression under TNF antagonist therapy.Pharmacodynamics of TNF-α inhibitors in psoriasis.Biologic fatigue in psoriasis.Five-year experience with infliximab: Follow up of the product familiarisation program.Development of paradoxical inflammatory disorders during treatment of psoriasis with TNF inhibitors: a review of published cases.Multidrug resistant miliary tuberculosis during infliximab therapy despite tuberculosis screening.The safety of treatments used in pyoderma gangrenosum.Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation.German S3-guidelines on the treatment of psoriasis vulgaris (short version).Prevalence and management of panic attacks during infliximab infusion in psoriatic patients.S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update.
P2860

Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.

Item
http://www.wikidata.org/entity/Q33371653
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.
@ast
Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.
@en
type
label
Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.
@ast
Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.
@en
prefLabel
Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.
@ast
Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2133.2006.07316.X
P407
P433
P478
P50
P577
P698